Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Understand value investing vs growth investing for beginners to determine which strategy suits you best. Make informed investment decisions.
24,931 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
NVIDIA CEO Jensen Huang has framed a $40 trillion TAM for labor automation via robotics, prompting a broader look at ...
When the Fed signals a policy shift, traders rush to position. This article dives into the appeal of a 3X Financial B...
As markets wobble in early 2026, blue-chip art is moving from galleries to mainstream portfolios. This piece explains...
Peter Buffett’s late discovery of his father’s billionaire status tracks a broader story about wealth, privacy, and r...
A single housing metric has crossed a major milestone, signaling potential changes in loan access and affordability. ...
Private markets promise higher potential returns through the ill-liquidity premium, but they require patience, carefu...
A Dallas muralist claims FIFA and related parties covertly painted over a public art piece to push World Cup branding...
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...